Other medications, such as dopamine receptor agonists and anticholinergics, also have limitations, including impulse-control disorders and various anticholinergic side effects (11, 12)
[2] Dulaglutide (Trulicity), another once-weekly injectable GLP-1 agonist, demonstrates a somewhat more favourable gastrointestinal tolerability profile in some studies, with nausea reported in approximately 8-12% of patients at lower doses, though rates increase with higher doses (3
For patients who are genuinely needle-averse, we discuss alternative delivery methods when available
TMA wird anschliessend vom Darm in die Leber transportiert und dort vom Leberenzym flavinhaltige Monooxygenase 3 (FMO3) in Trimethylamin-N-Oxid (TMAO) umgewandelt
The solution is straightforward but requires intentional planning: prioritize protein intake at every meal and combine it with resistance training